Combination drug therapy for gastroesophageal reflux disease

Annals of Pharmacotherapy

Volumn 36, Issue 5, 2002, Pages 912-916

  Cross, L Brian ^a   Justice, Lori N ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Combination therapy; Gastroesophageal reflux disease; Histamine2 receptor antagonists; Proton pump inhibitors

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERANCE; GASTROESOPHAGEAL REFLUX; HUMAN; NONHUMAN; PRIORITY JOURNAL; STOMACH PH;

ANTI-ULCER AGENTS; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; GASTROESOPHAGEAL REFLUX; H(+)-K(+)-EXCHANGING ATPASE; HISTAMINE H2 ANTAGONISTS; HUMANS; HYDROGEN-ION CONCENTRATION; OMEPRAZOLE; PROTON PUMPS; RANITIDINE; TREATMENT OUTCOME;

EID: 0036096443     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10247     Document Type: Article

References (25)

1. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis
2. A comparison of five maintenance therapies for reflux esophagitis
3. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease
4. Medical therapy for chronic reflux esophagitis: Long term follow-up
5. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: A double blind placebo-controlled trial
6. Parietal cell structure during inhibition of acid secretion
7. Anatomy and anomalies of the stomach and duodenum
8. Gastric acid secretion
9. Peptic ulcer and its complications
10. Proton pump inhibitors: Better before breakfast than without breakfast
11. Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs
12. Overview of medical therapy for gastroesophageal reflux disease
13. Medical therapy: Management of the refractory patient
14. Nocturnal recovery of gastric secretion on twice daily dosing of proton pump inhibitors
15. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease
16. Roles of gastric acid and pH in pathogenesis of gastro-oesophageal reflux disease
17. Appropriate acid suppression for management of gastro-oesophageal reflux disease
18. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects
19. Zantac 75 = Prilosec 20 mg to block nighttime acid
20. Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH
21. 2RAs - Another viewpoint
22. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
23. Persistent acid secretion during omeprazole therapy: A study of gastric acid profiles in patients demonstrating failure of omeprazole therapy
24. Omeprazole 20 mg b.i.d vs. lansprazole 30 mg b.i.d. in control of intragastric acidity
25. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: Follow-up of a randomized controlled trial